| NCT ID | NCT03132922 |
| Title | MAGE-A4c1032T for Multi-Tumor |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Adaptimmune |
| Indications |
head and neck squamous cell carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma urethra transitional cell carcinoma |
| Therapies | |
| Age Groups: | adult senior |